Page 950 - Small Animal Internal Medicine, 6th Edition
P. 950

922    PART VII   Metabolic and Electrolyte Disorders


                                                                 of hypokalemia include hypokalemic nephropathy, which
                   BOX 53.5                                      is characterized by chronic tubulointerstitial nephritis,
  VetBooks.ir  Causes of Hypokalemia in Dogs and Cats            impaired renal function, and azotemia and manifests clini-
                                                                 cally as polyuria, polydipsia, and impaired urine concen-
                                                                 trating capability; hypokalemic polymyopathy, which is
             Transcellular Shifts (ECF to ICF)
             Metabolic alkalosis                                 characterized by increased serum creatine kinase activity
             Hypokalemic periodic paralysis (Burmese cats)       and electromyographic abnormalities; and paralytic ileus,
                                                                 which manifests clinically as abdominal distention, anorexia,
             Increased Loss                                      vomiting, and constipation. Hypokalemic nephropathy and
             Gastrointestinal fluid loss (vomiting, diarrhea)*   polymyopathy are most notable in cats.
             Chronic kidney disease, especially in cats*
             Diabetic ketoacidosis*                              Diagnosis
             Diet-induced hypokalemic nephropathy in cats        Measurement of the serum potassium concentration iden-
             Distal (type I) renal tubular acidosis
             Proximal (type II) renal tubular acidosis after sodium   tifies hypokalemia. Once it has been identified, a careful
               bicarbonate treatment                             review of the history, physical findings, CBC, serum bio-
             Postobstructive diuresis                            chemistry panel, and urinalysis usually provides clues to the
             Primary hyperaldosteronism                          cause (see  Box 53.5). If the cause is not readily apparent
             Chronic liver disease                               after review of this information, other less likely causes for
             Hyperthyroidism                                     hypokalemia  should  be  considered,  such  as  renal  tubular
             Hypomagnesemia                                      acidosis,  or  another  renal  potassium-wasting  disorder,
                                                                 primary hyperaldosteronism, and hypomagnesemia. To
             Iatrogenic Causes*                                  help differentiate renal from nonrenal sources of potas-
             Potassium-free fluid administration (e.g., 0.9% saline)  sium loss,  the clinician may need to determine the frac-
             Parenteral nutritional solutions                    tional excretion of potassium on the basis of a single urine
             Insulin- and glucose-containing fluid administration
             Sodium bicarbonate therapy                          and serum potassium and creatinine concentration or may
             Loop (e.g., furosemide) and thiazide diuretics      need  to  evaluate  24-hour  urine  potassium  excretion  (see
             Low dietary intake                                  Chapter 39).
             Pseudohypokalemia                                   Treatment
             Hyperlipidemia (dry reagent methods; flame photometry)  Therapy is indicated if the serum potassium concentration is
             Hyperproteinemia (dry reagent methods; flame        less than 3.5 mEq/L, if clinical signs related to hypokalemia
               photometry)                                       are present, or if a serum potassium loss is anticipated (e.g.,
             Hyperglycemia (dry reagent methods)                 insulin therapy in diabetic ketoacidosis [DKA]) and the ani-
             Azotemia (dry reagent methods)                      mal’s ability to compensate for the loss is impaired. The goal
                                                                 of therapy is to reestablish and maintain normokalemia
            ECF, Extracellular fluid; ICF, intracellular fluid.
            *Common causes.                                      without inducing hyperkalemia.
            Modified from DiBartola SP, Autran de Morais H: Disorders of   Potassium chloride is the compound most commonly
            potassium: hypokalemia and hyperkalemia. In DiBartola SP, editor:   used for parenteral potassium supplementation, in part
            Fluid, electrolyte, and acid-base disorders in small animal practice,   to help promote chloride as well as potassium repletion.
            ed 4, St Louis, 2012, Saunders Elsevier.             IV administration is preferred, although potassium chlo-
                                                                 ride can be given subcutaneously as long as the concentra-
                                                                 tion of potassium does not exceed 30 mEq/L. In dogs and
            most common clinical sign of hypokalemia is generalized   cats with normal renal function, the maintenance amount
            skeletal muscle weakness. In cats ventroflexion of the neck   of potassium supplementation is approximately 20 mEq/L
            (see Chapter 67), forelimb hypermetria, and a broad-based   of fluids. The amount  of potassium  first added to fluids
            hindlimb stance may be observed. The timing of onset of   depends  on the animal’s  serum  potassium  concentration
            hypokalemia-induced weakness is extremely variable among   (Table 53.3) and the amount of potassium already present
            animals. Cats seem more susceptible than dogs to the del-  in  the  fluids  (see  Table  53.1).  The  rate  of  IV  potassium
            eterious effects of hypokalemia. In dogs, signs may not be   administration should not exceed 0.5 mEq/kg/h. The rate
            evident until the serum potassium concentration is less than   of potassium administration can be increased cautiously to
            2.5 mEq/L, whereas in cats signs can be seen when the serum   1.0 mEq/kg/h in patients with profound hypokalemia and
            potassium concentration is between 3 and 3.5 mEq/L.  normal or increased urine output. Close ECG monitoring is
              Cardiac consequences of hypokalemia include decreased   recommended.
            myocardial contractility, decreased cardiac output, and dis-  It is difficult to estimate the amount of potassium required
            turbances in cardiac rhythm. Cardiac disturbances assume   to reestablish normal potassium balance on the basis of the
            a variable clinical expression, often evidenced only by elec-  serum potassium concentration because potassium is pri-
            trocardiography (see  Box 53.4). Other metabolic effects   marily an intracellular cation. As such, serial measurement
   945   946   947   948   949   950   951   952   953   954   955